IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.
Matesanz
Fuencisla
F
Caro-Maldonado
Alfredo
A
Fedetz
Maria
M
Fernández
Oscar
O
Milne
Roger L
RL
Guerrero
Miguel
M
Delgado
Concepción
C
Alcina
Antonio
A
D016022:Case-Control Studies; D016009:Chi-Square Distribution; D004252:DNA Mutational Analysis; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000235:genetics*; D008297:Male; D009103:Multiple Sclerosis / Q000453:epidemiology / Q000235:genetics*; D016017:Odds Ratio; D011110:Polymorphism, Genetic / Q000235:genetics*; D012235:Rhodamines / Q000378:metabolism; D013030:Spain / Q000453:epidemiology; D044465:White People / Q000235:genetics
C508017:IL2RA protein, human; D053645:Interleukin-2 Receptor alpha Subunit; D012235:Rhodamines; C103221:Texas Red-X succinimidyl ester